Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.20 – $2.90
8% from low
Exchange
OTC Link
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $232.2K | $184.3K | $194.4K | $160.8K | $94.1K | $119.3K | $84.5K | $70.7K |
| Cost of revenue | $97.2K | $91.6K | $62.7K | $45.3K | $30.5K | $35.9K | $27.9K | $23.9K |
| Gross profit | $135.0K | $92.8K | $131.7K | $115.5K | $63.5K | $83.4K | $56.6K | $46.8K |
| Gross margin | 58.1% | 50.3% | 67.7% | 71.8% | 67.5% | 69.9% | 67.0% | 66.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$185.7K | −$286.5K | −$248.8K | −$370.8K | −$403.6K | −$444.6K | −$378.9K | −$363.2K |
| EBITDA | −$616.6K | $1.9M | $732.4K | −$370.8K | −$167.0K | −$441.3K | −$378.9K | −$363.2K |
| Net income | −$617.5K | $1.9M | $559.1K | −$372.0K | −$420.5K | −$472.7K | −$418.0K | −$413.6K |
| Net margin | -265.9% | 1039.3% | 287.5% | -231.3% | -447.1% | -396.1% | -494.8% | -585.1% |
| EPS (diluted) | -1.31 | 3.14 | 0.19 | -0.07 | -0.08 | -0.09 | -0.08 | -0.08 |
Annual figures · source: Financial Modeling Prep
CYDUCT DIAGNOSTICS INC
No one on the platform currently holds CYDX.
No tracked institution reports a position in CYDX as of their last filing.
No one on the platform has traded CYDX yet.
| $57185 |
| — |
| EPGNFEpigenomics AG | $1.12 | +0.00% | $982212 | — |
| ESMCEscalon Medical Corp. | $0.19 | +5.56% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 30.3× sales vs its 27.7× historical median P/S.
Fair value ≈ $0.38 · price $0.42 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.